- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02114125
Effects of the Physical Activity and Cognitive Training Program
The Effects of Physical Activity and Cognitive Training in Improving Cognitive Function of Institutionalized Older Residents
Investigators assume that there are some positive effects of cognitive training and physical activities on cognitive function, depression and quality of life in a sample of older residents in long-term care facilities.
The purpose of this study is to explore the effects of various interventions (physical activity, cognitive training, integration of physical activity and cognitive training) on different outcome indictors in institutionalized older residents.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- to develop an intervention protocol that achieves clinical development objectives in a scientifically rigorous and time efficient manner.
- to further analyze the effects of the various interventions and make a comparison of dose-response relation and efficacy.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan Unversity Hospital
-
Contact:
- Meei-Fang Lou, PhD
- Phone Number: 88441 886-2-23123456
- Email: mfalou@ntu.edu.tw
-
Contact:
- Chien-Ning Tseng, PhC
- Phone Number: 88441 886-2-23123456
- Email: kabyjean@gmial.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 65 year and older
- Able to communicate verbally
- Able to discern 5*5 cm2 picture from a viewing distance of 20 cm
- Able to hear a sound of normal speech from a distance of 20 cm
- Able to sit in a chair or wheelchair independently for more than 30 minutes without changes in vital signs and awareness and without physical discomfort
- Has cognitive decline status assessing by CASI 2.0
- Lived in long-term care facilities during the study
Exclusion Criteria:
- Complete aphasia, blindness, deafness or completely dependent
- Unstable angina, arrythmia, myocardial infarction history, postural hypotension, transient cerebral hypoxia or other psychiatric disorders except depression
- Thrombophlebitis, or malignancy of the limbs.
- Refusal by patient or family member.
- Others. Reason to be well documented.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care Group:
Usual care consists of standard institutionalized services provided by physicians, nurses, and support staff (e.g., nurse assistants, social workers) in long-term care facilities.
|
|
|
Experimental: High-intensity physical activity (5PA)
The intervention conducts the group-based physical activity, 5 days per- week for 8 weeks.
|
group-based physical activity
|
|
Experimental: Low-intensity PA and CT(3PA+2CT)
The intervention conducts 3 days per-week physical activity and 2 days per-week cognitive training for 8 weeks.
|
group-based physical activity
individual-based, multi-domains cognitive training
|
|
Experimental: High-intensity PA and CT (5PA+5CT)
The intervention conducts the individual-based, multi-domains cognitive training, 5days per- week and group-based physical activity, 5 days per- week and for 8 weeks.
|
group-based physical activity
individual-based, multi-domains cognitive training
|
|
Experimental: Low-intensity cognitive training (2CT)
The intervention conducts the individual-based, multi-domains cognitive training, 2 days per- week for 8 weeks.
|
individual-based, multi-domains cognitive training
|
|
Experimental: High-intensity cognitive training (5CT)
The intervention conducts the individual-based, multi-domains cognitive training, 5 days per- week for 8 weeks.
|
individual-based, multi-domains cognitive training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Cognitive Function at 8 weeks and 16weeks
Time Frame: pre-treatment (0 week, T0), post-treatment (8 weeks, T1) and follow-up (16 weeks, T2 )
|
Cognitive Function: Cognitive Assessment Screening Instrument (CASI) 2.0 in Chinese version
|
pre-treatment (0 week, T0), post-treatment (8 weeks, T1) and follow-up (16 weeks, T2 )
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Depression at 8 weeks and 16weeks
Time Frame: pre-treatment (0 week, T0), post-treatment (8 weeks, T1) and follow-up (16 weeks, T2 )
|
Depression: Geriatric depression scale (GDS)-15 in Chinese version.
|
pre-treatment (0 week, T0), post-treatment (8 weeks, T1) and follow-up (16 weeks, T2 )
|
|
Change from Baseline Quality of Life at 8 weeks and 16weeksStatus:
Time Frame: pre-treatment (0 week, T0), post-treatment (8 weeks, T1) and follow-up (16 weeks, T2 )
|
Quality of Life: Short Form-12 (SF-12) in Chinese version.
|
pre-treatment (0 week, T0), post-treatment (8 weeks, T1) and follow-up (16 weeks, T2 )
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Meei-Fang Lou, PhD, Department of Nursing, College of Medicine, National Taiwan University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201112011RID
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.